These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12359130)

  • 1. From bench to bedside: a diagnostics framework for pharmacogenetics research.
    Katz DA
    Mol Genet Metab; 2002; 77(1-2):57-60. PubMed ID: 12359130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of asthma.
    Hall IP
    Chest; 2006 Dec; 130(6):1873-8. PubMed ID: 17167011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
    Stingl JC; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics and asthma: false hope or new dawn?
    Hall IP; Sayers I
    Eur Respir J; 2007 Jun; 29(6):1239-45. PubMed ID: 17540786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet?
    Perera MA; Innocenti F; Ratain MJ
    Pharmacotherapy; 2008 Jun; 28(6):755-68. PubMed ID: 18503403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
    Wang L; Weinshilboum R
    Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priorities and standards in pharmacogenetic research.
    Need AC; Motulsky AG; Goldstein DB
    Nat Genet; 2005 Jul; 37(7):671-81. PubMed ID: 15990888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of asthma: where are we now?
    Larj MJ; Bleecker ER
    Clin Chest Med; 2006 Mar; 27(1):109-17, vii. PubMed ID: 16543056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics: bench to bedside.
    Weinshilboum R; Wang L
    Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast.
    Klotsman M; York TP; Pillai SG; Vargas-Irwin C; Sharma SS; van den Oord EJ; Anderson WH
    Pharmacogenet Genomics; 2007 Mar; 17(3):189-96. PubMed ID: 17460547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.
    Drazen JM; Yandava CN; Dubé L; Szczerback N; Hippensteel R; Pillari A; Israel E; Schork N; Silverman ES; Katz DA; Drajesk J
    Nat Genet; 1999 Jun; 22(2):168-70. PubMed ID: 10369259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the pharmacogenetics of asthma treatment.
    Weiss ST; Litonjua AA; Lange C; Lazarus R; Liggett SB; Bleecker ER; Tantisira KG
    Pharmacogenomics J; 2006; 6(5):311-26. PubMed ID: 16568148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of irinotecan: a promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecan.
    Ando M; Hasegawa Y; Ando Y
    Invest New Drugs; 2005 Dec; 23(6):539-45. PubMed ID: 16267624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.
    Lu M; Lewis CM; Traylor M
    BMC Med Genomics; 2017 Jun; 10(1):47. PubMed ID: 28629370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics: from bench to byte.
    Swen JJ; Wilting I; de Goede AL; Grandia L; Mulder H; Touw DJ; de Boer A; Conemans JM; Egberts TC; Klungel OH; Koopmans R; van der Weide J; Wilffert B; Guchelaar HJ; Deneer VH
    Clin Pharmacol Ther; 2008 May; 83(5):781-7. PubMed ID: 18253145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of atherosclerosis: part II: clinical implications.
    Lusis AJ; Fogelman AM; Fonarow GC
    Circulation; 2004 Oct; 110(14):2066-71. PubMed ID: 15466657
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics of drug transporters in the enterohepatic circulation.
    Stieger B; Meier PJ
    Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.